ConductScience.org, home

Gene · 9407

TMPRSS11D: transmembrane serine protease 11D

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. TMPRSS11D: transmembrane serine protease 11D. Genes, record 9407. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9407

On this page

Gene

Symbol
TMPRSS11D
HGNC
Name
transmembrane serine protease 11D
HGNC
NCBI Gene ID
9407
NCBI Gene
HGNC ID
HGNC:24059
HGNC
Ensembl
ENSG00000153802
NCBI Gene
Aliases
ASP, HAT
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O60235Transmembrane protease serine 11D4182Ensembl, GeneID, HGNC

Source UniProt

Patents78

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2025529142 A2025-09-044973O60235Espacenet
US 12371689 B22025-07-294973O60235Espacenet
KR 1020230021759 A2023-02-1418O60235Espacenet
US 11446398 B22022-09-2090890O60235Espacenet
US 11400116 B22022-08-023002O60235Espacenet
JP 2022524081 A2022-04-27193861O60235Espacenet
US 11078247 B22021-08-0311761O60235Espacenet
US 10863729 B22020-12-1518O60235Espacenet
US 10533225 B22020-01-14193O60235Espacenet
JP 2019511918 A2019-05-0971O60235Espacenet

1 to 10 of 78

See all 78 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,153

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleTMPRSS11D papersNewest fiscal year
P30CA008748Cancer Center Support Grant142025
P30CA016672Cancer Center Support Grant142025
P30CA010815Consolidated Basic Cancer Research Program72025
P30CA021765Cancer Center Support Grant (CCSG)72025
R01HG002939Development and Maintenance of RepeatMasker and RepeatModeler62025
P01CA096832NORMAL & NEOPLASTIC GROWTH IN THE BRAIN52025
P30CA076292Moffitt Cancer Center Support Grant52025
P30ES010126UNC Center for Environmental Health and Susceptibility52025
R01CA178441Combinatorial epigenetic-based prevention of breast cancer52025
R01DA007359Molecular Studies of Cocaine Action in Brain52025

1 to 10 of 2,153Source NIH's project files

See all 2,153 nih grants

Papers3,095

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Comparative transcriptomics analysis of histone deacetylases, transcription factors, and ion channel genes in human iPSC-cardiomyocytes vs. the adult human heart.J Precis Med (Amst)202642644057PubTator, text miningPubMed
HAT regimen attenuates NF-κb-driven megakaryocyte apoptosis and neuronal cell death in sepsis: convergent mechanisms protecting thrombocytopenia and cognitive function.Front Cell Dev Biol202642548835PubTator, text miningPubMed
Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications.Pharmacol Res202642468581PubTator, text miningPubMed
Acetylation as a dynamic regulatory interface between plant stress memory, cross-tolerance, and crop resilience design.Front Plant Sci202642389139PubTator, text miningPubMed
Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches.Cancer Immunol Immunother202642215810PubTator, text miningPubMed
αKG-mediated carnitine synthesis drives DNA repair via histone acetylation.Nature202642203879PubTator, text miningPubMed
Unraveling the layers of epigenetic control in respiratory antiviral defense.J Virol202642159289PubTator, text miningPubMed
Promising Synthetic Antioxidants of Dimethyltin(IV) Formulations Derived From 4-Acylated Edaravone: Design, DFT Assisted Optimized Molecular Structure and Mechanistic Insights into SET Versus HAT Pathways for Antioxidant Activity.
J Biochem Mol Toxicol202642101074PubTator, text miningPubMed
Radical Quenching and LOX Inhibiting Properties of Indole Derivatives: A Plausible Mechanism of Action Through HAT, SET-PT and SPLET Pathway.J Fluoresc202642090043PubTator, text miningPubMed
Genetic mutations and inhibitors of p300 and CBP.Biochim Biophys Acta Rev Cancer202642061730PubTator, text miningPubMed

1 to 10 of 3,095

See all 3,095 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/9407

GET https://conductscience.org/api/genes/v1/9407/patents?page=2